Serum and bronchoalveolar lavage fluid galactomannan assays in patients with pulmonary aspergilloma.
cross_sectional · Level IV
Where this comes from
- Record sourced from PubMed, PMID 21427387.
- Also identified by DOI 10.1093/cid/cir027.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The sensitivities of the serum and bronchoalveolar lavage galactomannan (GM) assays in 48 patients with pulmonary aspergilloma were 38% (13 of 34; 95% confidence interval [CI], 22%-56%) and 92% (33 of 36; 95% CI, 78%-98%), respectively. The positivity of serum GM assays was significantly higher in patients with hemoptysis than in those without hemoptysis (52% vs 9%; P=.02).
Medical subject headings
- Bronchoalveolar Lavage Fluid
- Clinical Laboratory Techniques
- Mannans
- Pulmonary Aspergillosis
- Serum